Background & Aims of the Study: one of the most important health aspects health care systems is patient safety and medication errors can threaten this safety. The purpose of this research was evaluation of refusing to report the medication errors and effect on Patent safety in Razi teaching hospital after healthcare reform during 2014-2015. Materials and Methods: This study is cross-sectiona...

the risks of transmitting viral infection by blood and plasma-derived products have long been known and still remain an area of concern. in this study, in the process of purifying human factor vii from prothrombin complex, sid treatment using tri-n-butyl phosphate and tween 80 was employed and its capability and efficacy was studied. the results indicated that the process did not affect the bio...

accidents allocate more than 30 percent causes of mortality and are the most common reason of mortality in children after one year old. thus, in order to provide children health, education of road safety is essential and children should be more aware about road safety necessities and learn  the methods of life maintenance proportionate with own age and needs. there is a significant note that ed...

Background: Recombinant activated factor VII induces hemostasis in patients with coagulopathy disorders. AryoSeven™ as a safe Iranian Recombinant activated factor VII has been available on our market. This study was performed to establish the safety of AryoSeven on patients with coagulopathy disorder. Methods: This single-center, descriptive,...

Background: Considering the increasing number of patients with hemophilia and infrastructure requirements for a comprehensive approach, development of a recombinant factor has become a milestone. The objective of this study was to assess the safety, efficacy and non inferiority of Safacto (Recombinant factor VIII) compared with plasma-derived factor in the treatment of hemophilia A. Methods: 10 ...